Zenith Technologies Appoints Serialization Director

Zenith Technologies, a global life science technology firm, with headquarters in Ireland, has appointed Carlos Machado as serialization director to lead the company’s sales, operations, implementation and post project support services in the U.S.

The appointment comes as the pharmaceutical industry faces the challenge of complying with new legal requirements for the authentication and barcoding of licensed drug products from November 2017 in the U.S. and early 2019 in Europe.

Mr. Machado joins Zenith Technologies with significant experience of assisting pharmaceutical manufacturers with track and trace technologies, having worked on more than 75 serialization projects from both an operations and delivery perspective.

In his former role as director of global operations at a leading anti-counterfeiting technology provider, Mr. Machado helped to pioneer the serialization concept and define the future of authentication.

“Serialization is a real challenge for our customers and it’s an important time for us to add further expertise to our team,” said Jim Lehane, director, Zenith Technologies. “Carlos’ background in track and trace technologies and his knowledge of the implementation challenges pharmaceutical manufacturers face, make him ideally suited to lead our serialization offering in the U.S., helping our customers achieve seamless compliance with the new regulations.”

The announcement is the next stage in Zenith Technologies’ goal to assist companies in the US and Europe with the challenge of serialization. The company recently announced a global partnership with software provider SEA Vision to support pharmaceutical companies with the installation and integration of serialization solutions across drug manufacturing sites.